Acta Medica International

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 6  |  Issue : 1  |  Page : 11--16

Thyroid-stimulating hormone in hypothyroidism – How high is too high?


Ruth Priya Senthiappan1, Smitha Bhat2, Sudeep Krishna3 
1 Department of Medicine, SDM College, Dharwad, Karnataka, India
2 Departmen of Medicine, Father Muller Medical College, Mangalore, Karnataka, India
3 Departemnt of Endocrinology, Father Muller Medical College, Mangalore, Karnataka, India

Correspondence Address:
Dr. Smitha Bhat
Department of Medicine, Father Muller Medical College, Mangalore, Karnataka
India

Background: The prevalence of hypothyroidism in the developed world is about 4-5% and in India is 10.9%. The goal of treating hypothyroidism is to maintain thyrotropin (TSH) levels within the normal reference range. Studies have shown that even within the normal range of TSH, patients with low normal TSH (LNT) have better outcomes when compared to patients with high normal TSH (HNT). Aims and Objectives: Our study aimed to find whether patients treated at a dose of levothyroxine resulting in an LNT had improved clinical outcomes and biochemical parameters, when compared to those on a levothyroxine dose resulting in an HNT. Materials and Methods: 180 patients with hypothyroidism on treatment, who had a TSH of 0.27-4.2mIU/L and had been on treatment with a stable dose of at least 50 micrograms of levothyroxine for at least 6 months were administered the Thyroid Symptom Questionnaire. TSH was assayed. Blood pressure and BMI were measured. Serum lipids were measured by spectrophotometry. Results: We found that patients with LNT and HNT did not differ with respect to cognitive symptoms , feelings of coldness, lethargy and fatigue. However, patients with LNT had a better lipid profile (mean LDL 132.24 in HNT and 115.39 in LNT p= 0.08) and lower BMI (1.045kg/m 2 lower in LNT compared to HNT) compared to HNT. Conclusion: Treating patients with a dose of thyroxine titrated to achieve LNT might decrease the cardiovascular risk by improving the lipid profile and BMI.


How to cite this article:
Senthiappan RP, Bhat S, Krishna S. Thyroid-stimulating hormone in hypothyroidism – How high is too high?.Acta Med Int 2019;6:11-16


How to cite this URL:
Senthiappan RP, Bhat S, Krishna S. Thyroid-stimulating hormone in hypothyroidism – How high is too high?. Acta Med Int [serial online] 2019 [cited 2019 Nov 14 ];6:11-16
Available from: http://www.actamedicainternational.com/article.asp?issn=2349-0578;year=2019;volume=6;issue=1;spage=11;epage=16;aulast=Senthiappan;type=0